Latest Cost Savings News

Green360 Technologies has sealed its first binding supply contract with Holcim and ramped up MKX production, positioning itself as Australia’s leading supplier of low-carbon cement alternatives amid tightening SCM markets.

Elixinol Wellness posted a record quarterly revenue of $4.3 million in Q2 FY26, driven by The Healthy Chef's expansion and a 45% gross margin. Cost cuts helped deliver positive underlying operating cash flow for the third straight quarter despite some one-off expenses.

Whitehaven Coal delivered a robust finish to FY26, hitting top-end guidance for production and sales while improving safety and reducing costs.

Blackpearl Group reported a 95% year-on-year ARR increase to $27.2 million in Q1 FY27, alongside a strategic shift to higher-quality revenue and a clear path to reducing EBITDAF losses through FY27. The company also launched its Platform as a Service offering ahead of schedule, underpinning its evolving revenue model.

Adherium reports a near tenfold surge in recurring revenue from remote patient monitoring and clinical evidence supporting significant cost reductions in respiratory care.

Patrys Limited is pushing forward with a proprietary injectable formulation of quetiapine targeting the lucrative delirium treatment market, leveraging a faster, lower-cost FDA 505(b)(2) regulatory pathway and strong patent protection.

The Star Entertainment Group reported a significant improvement in quarterly EBITDA loss alongside stable revenue, completing key joint venture exit and refinancing milestones that boosted liquidity to $267 million.

PRL Global has secured a decade-long rail haulage contract, marking a pivotal shift from container to bulk logistics at its Ardmore Phosphate Mine. This move aims to cut transport costs and ramp up shipments starting August 2026.

Complii FinTech Solutions reported modest ARR growth and a key institutional contract in Q4 FY26, while advancing product development and managing cash flow pressures.

Change Financial has delivered strong FY26 results with revenue up 21% and underlying EBITDA soaring 17-fold, driven by scaling of its Vertexon PaaS platform and expanding client base.

Genetic Signatures has completed a major restructure delivering $5 million in annual savings from FY2027 and secured a decade-long supply contract with Denmark’s Hvidovre Hospital, while posting $14.8 million revenue for FY2026 amid market pressures.

Eden Innovations is broadening its EdenCrete®Pz7 footprint with Amrize by adding four new concrete plants in Texas, Minnesota, and Toronto, supported by initial US$32,000 orders.